Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
481-495 of 2993 results
Meridian receives FDA clearance for new molecular whooping cough test claims
By MDBR Staff Writer
Meridian Bioscience announced it has received clearance from the U.S. Food and Drug Administration (FDA) for new claims for its illumigene Pertussis molecular amplification test.
Diagnostics > In Vitro Diagnostics > News
Pfizer, Novartis, Thermo Fisher Scientific partner to develop NGS oncology test
By MDBR Staff Writer
Thermo Fisher Scientific has partnered with drugmakers Novartis and Pfizer to develop next-generation sequencing-based (NGS) companion diagnostic (CDx) test.
Diagnostics > In Vitro Diagnostics > News
Roche’s new test wins FDA approval as companion diagnostic for NSCLC therapies
By MDBR Staff Writer
Switzerland’s Roche has received approval from the US Food and Drug Administration (FDA) for its cobas epidermal growth factor receptor (EGFR) mutation test v2 as a companion diagnostic for non-small cell lung cancer (NSCLC) therapies.
Diagnostics > In Vitro Diagnostics > News
Rosetta provides update on performance data and launch of RosettaGX Reveal
By MDBR Staff Writer
Rosetta Genomics announces additional performance data from the recently-completed, blinded validation study of RosettaGX Reveal, its microRNA-based diagnostic assay for the classification of indeterminate thyroid nodules.
Diagnostics > In Vitro Diagnostics > News
Roche launches new H&E tissue staining solution
By MDBR Staff Writer
Roche announced the launch of the VENTANA HE 600 system, the latest fully automated hematoxylin and eosin (H&E) tissue staining system that enhances patient and technician safety and produces exceptional staining quality.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific reveals results of prostate cancer screening study
By MDBR Staff Writer
Thermo Fisher Scientific, along with Karolisnka Institute, has revealed the results of the Stockholm 3 (STHLM3) clinical study, designed to develop an effective test to screen prostate cancer than using the prostate-specific antigen (PSA) alone.
Diagnostics > In Vitro Diagnostics > News
Roche expands cobas 4800 system menu with HIV-1, HCV and HCV genotyping tests
By MDBR Staff Writer
Roche announced the commercial availability of the cobas HIV-1, HCV and HCV genotyping (GT) assays in countries accepting the CE mark.
Diagnostics > In Vitro Diagnostics > News
Tute Genomics acquires Knome
By MDBR Staff Writer
Tute Genomics, the leader in clinical sequencing informatics, today announced the acquisition of key assets of Knome, a renowned human-genome interpretation company whose systems and services helped spearhead several of the greatest commercial advancements in modern human genetics.
Diagnostics > In Vitro Diagnostics > News
Rubicon Genomics announces Eurofins Scientific will distribute its suite of DNA library preparation kits in US
By MDBR Staff Writer
Rubicon Genomics announced an agreement with Eurofins Genomics for U.S. distribution of its DNA library preparation products, including the ThruPLEX DNA-seq kit and Rubicon's new ThruPLEX Plasma-seq kit.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific gets FDA approval for new immunoassay to detect hydrocodone
By MDBR Staff Writer
Thermo Fisher Scientific has received 510(k) approval from the US Food and Drug Administration (FDA) for its new immunoassay to specifically detect hydrocodone.
Diagnostics > In Vitro Diagnostics > News
Sinocare to acquire Nipro Diagnostics for $273m
By MDBR Staff Writer
China-based Sinocare Group has signed an agreement with Japan’s Nipro Corporation to acquire its wholly-owned subsidiary Nipro Diagnostics, for around $273m in cash.
Diagnostics > In Vitro Diagnostics > News
Origin Sciences introduces new OriCol microbiome research kit
By MDBR Staff Writer
Medical technology firm Origin Sciences has introduced new OriCol microbiome research kit, specifically developed for use in gut microbiome research.
Diagnostics > In Vitro Diagnostics > News
Vermillion receives CE mark approval for Overa test to detect ovarian cancer
By MDBR Staff Writer
Bio-analytical solutions firm Vermillion has received CE mark approval for its next generation OVA1 test to detect the risk of malignancy for ovarian cancer.
Diagnostics > In Vitro Diagnostics > News
NeoGenomics to acquire GE Healthcare's Clarient for $275m
By MDBR Staff Writer
US-based genetic testing services provider NeoGenomics has agreed to acquire GE Healthcare's Life Sciences business unit Clarient and its wholly-owned subsidiary Clarient Diagnostic Services, for around $275m.
Diagnostics > In Vitro Diagnostics > News
Luminex and Bio-Techne extend and expand partnership
By MDBR Staff Writer
Luminex and Bio-Techne announced the signing of a new distribution and supply agreement through 2020.
Diagnostics > In Vitro Diagnostics > News
481-495 of 2993 results